ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

TYO:4886 Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	6,621	10,603	13,738	14,505	12,103	10,514
Short-Term Investments	827	555	3,500	3,400	5,000	-
Cash & Short-Term Investments	7,448	11,158	17,238	17,905	17,103	10,514
Cash Growth	-45.66%	-35.27%	-3.72%	4.69%	62.67%	44.15%
Receivables	16,678	15,090	15,579	15,217	14,482	13,153
Inventory	26,874	26,333	20,402	17,687	15,060	14,372
Other Current Assets	6,825	5,466	2,924	2,950	2,912	1,893
Total Current Assets	57,825	58,047	56,143	53,759	49,557	39,932
Property, Plant & Equipment	19,268	18,709	11,263	10,796	10,936	12,675
Long-Term Investments	20,233	14,472	17,765	16,400	14,244	14,568
Goodwill	2,408	4,361	-	-	-	-
Other Intangible Assets	6,745	2,632	2,877	4,465	6,183	11,893
Long-Term Deferred Tax Assets	2,293	2,312	2,696	1,717	2,376	3,513
Other Long-Term Assets	1	1	1	1	1	1
Total Assets	108,773	100,534	90,745	87,138	83,297	82,582
Accounts Payable	9,538	9,146	7,355	5,860	6,841	6,455
Accrued Expenses	1,239	1,283	1,225	1,166	1,188	1,151
Short-Term Debt	3,702	2,521	300	300	300	350
Current Portion of Long-Term Debt	-	1,940	4,680	3,138	1,423	2,298
Current Income Taxes Payable	-	6,367	8,690	4,947	4,867	5,426
Other Current Liabilities	8,918	1,622	1,718	2,239	1,392	1,057
Total Current Liabilities	23,397	22,879	23,968	17,650	16,011	16,737
Long-Term Debt	8,932	6,441	4,505	9,185	12,323	13,747
Pension & Post-Retirement Benefits	-	206	-	5,433	5,730	6,419
Other Long-Term Liabilities	3,851	1,813	343	337	341	1,169
Total Liabilities	36,180	31,339	28,816	32,605	34,405	38,072
Common Stock	1,197	1,197	1,197	1,197	1,197	1,197
Additional Paid-In Capital	31	-	1,848	1,847	1,867	928
Retained Earnings	60,921	59,545	56,372	49,619	45,833	41,790
Treasury Stock	-658	-704	-3,287	-3,350	-3,479	-2,139
Comprehensive Income & Other	5,365	5,272	5,799	5,220	3,474	2,734
Total Common Equity	66,856	65,310	61,929	54,533	48,892	44,510
Minority Interest	5,737	3,885	-	-	-	-
Shareholders' Equity	72,593	69,195	61,929	54,533	48,892	44,510
Total Liabilities & Equity	108,773	100,534	90,745	87,138	83,297	82,582
Total Debt	12,634	10,902	9,485	12,623	14,046	16,395
Net Cash (Debt)	-5,186	256	7,753	5,282	3,057	-5,881
Net Cash Growth	-	-96.70%	46.78%	72.78%	-	-
Net Cash Per Share	-182.82	9.03	273.83	187.05	107.75	-207.42
Filing Date Shares Outstanding	28.4	28.36	28.33	28.29	28.18	28.37
Total Common Shares Outstanding	28.4	28.36	28.33	28.29	28.18	28.37
Working Capital	34,428	35,168	32,175	36,109	33,546	23,195
Book Value Per Share	2354.41	2302.59	2186.05	1927.97	1734.75	1568.87
Tangible Book Value	57,703	58,317	59,052	50,068	42,709	32,617
Tangible Book Value Per Share	2032.07	2056.04	2084.49	1770.12	1515.37	1149.67

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.